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Abstract 11 
Organisms in the environment are exposed to a number of pollutants from different compound 12 
groups. In addition to the classic pollutants like the polychlorinated biphenyls, polyaromatic 13 
hydrocarbons (PAHs), alkylphenols, biocides, etc., other compound groups of concern are 14 
constantly emerging. Pharmaceuticals and personal care products (PPCPs) can be expected to 15 
co-occur with other organic contaminants like biocides, PAHs and alkylphenols in areas 16 
affected by wastewater, industrial effluents and intensive recreational activity. In this study, 17 
representatives from these four different compound groups were tested individually and in 18 
mixtures in a growth inhibition assay with the marine algae Skeletonema pseudocostatum 19 
(formerly S. costatum) to determine whether the combined effects could be predicted by 20 
models for additive effects; the concentration addition (CA) and independent action (IA) 21 
prediction model. The eleven tested compounds reduced the growth of S. pseudocostatum in 22 
the microplate test in a concentration-dependent manner. The order of toxicity of these 23 
chemicals were irgarol > fluoxetine > diuron > benzo(a)pyrene > thioguanine > triclosan > 24 
propranolol > benzophenone 3 > cetrimonium bromide > 4-tert-octylphenol > endosulfan. 25 
Several binary mixtures and a mixture of eight compounds from the four different compound 26 
groups were tested. All tested mixtures were additive as model deviation ratios, the deviation 27 
between experimental and predicted effect concentrations, were within a factor of 2 from one 28 
or both prediction models (e.g. CA and IA). Interestingly, a concentration dependent shift 29 
from IA to CA, potentially due to activation of similar toxicity pathways at higher 30 
concentrations, was observed for the mixture of eight compounds. The combined effects of 31 
the multi-compound mixture were clearly additive and it should therefore be expected that 32 
PPCPs, biocides, PAHs and alkylphenols will collectively contribute to the risk in areas 33 
contaminated by such complex mixtures. 34 
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1. Introduction 38 
Organisms in the environment are exposed to a number of pollutants from different compound 39 
groups. Even though the environmental concentrations of individual pollutants might be too 40 
low to exert an effect on their own, the presence of several similarly acting compounds is 41 
expected to induce effects through combined toxicity at concentrations below their individual 42 
No Observed Effect Concentrations, NOECs (Backhaus et al., 2011; Kortenkamp, 2008). In 43 
addition to the classic pollutants like the polychlorinated biphenyls (PCBs), polyaromatic 44 
hydrocarbons (PAHs), alkylphenols, biocides, etc, other compound groups of concern are 45 
constantly emerging, and compounds from several of these classes have been found to co-46 
occur in marine waters (i.e. alkylphenols, biocides and pharmaceuticals) (Munaron et al. 47 
2012). One of the compound groups that have received a lot of attention in the last years is 48 
pharmaceuticals and personal care products (PPCPs). Most of these compounds are not 49 
regulated as pollutants and new PPCPs are continuously developed (Rosi-Marshall and Royer, 50 
2012). The PPCPs are generally introduced to the environment through municipal waste 51 
water, and via waste water from hospitals and labs (Daughton and Ternes, 1999; Fent et al., 52 
2006; Kummerer, 2009). The PPCPs and/or their metabolites and transformation products are 53 
transported to the seas by the rivers where they contribute to the contaminant load from 54 
recreational, shipping, agricultural and industrial activities. The emission of pharmaceuticals 55 
from human activities to the environment is expected to increase due to an increase in life 56 
expectancy, increase in living standard and affordability of drugs (Kummerer, 2010). Several 57 
PPCPs have been shown to be acute toxic to algae (Backhaus et al., 2011; Liu et al., 2011; 58 
Nunes et al., 2005), and a relatively large proportion (approx. 30%) of investigated 59 
pharmaceuticals are predicted to be potentially very toxic to aquatic organisms (Sanderson et 60 
al., 2004). The effect of individual PPCPs have been widely studied (Dave and Herger, 2012; 61 
Ellesat et al., 2010; Fent et al., 2006) and mixtures of PPCPs have been studied to a limited 62 
extent (Backhaus et al., 2011; DeLorenzo and Fleming, 2008). However few studies have 63 
investigated the effect of PPCPs in combination with other relevant contaminants like 64 
antifouling biocides, PAHs and industrial compounds.  65 
 66 
The mode of action (MoA) of biocides, PPCPs, PAHs and alkylphenols for the growth 67 
inhibition in algae are only known for some compounds and encompass both specific toxicity 68 
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and narcotic MoA. A majority of toxic compounds are believed to act through a narcotic MoA 69 
(baseline toxicity) which is assumed being caused by hydrophobicity-dependent and 70 
nonspecific interaction with biological membranes and membrane associated proteins (Mayer 71 
and Reichenberg, 2006; van Wezel and Opperhuizen, 1995). Chemicals that have a narcotic 72 
MoA are normally sufficiently lipophilic to accumulate in the lipid or the lipid-aqueous 73 
interface of biological membranes exerting polar narcosis (narcosis I) or nonpolar narcosis 74 
(narcosis II) (van Wezel and Opperhuizen, 1995), and leads to disruption of membrane 75 
functions and causes decreased activity and reduced reaction to external stimuli (LeBlanc, 76 
2004). The effective membrane concentrations of baseline toxicants are approximately equal 77 
in algae, daphnids and fish (Escher and Schwarzenbach, 2002). Biocides such as irgarol and 78 
diuron display a specific toxic MoA through inhibiting the photosystem (PS) II (Jones, 2005). 79 
By inhibiting PSII these biocides reduce the photosynthesising organisms’ ability to harvest 80 
energy and produce carbohydrates, ultimately leading to reduced ability to grow. The primary 81 
MoA of pharmaceuticals are usually well known as they are designed to exert a specific 82 
therapeutic effect. However, the biological targets for pharmaceuticals are not always present 83 
in non-mammalian organisms such as aquatic vertebrates and invertebrates. For instance, the 84 
human antidepressant fluoxetine and the beta-blocker propranolol, have previously been 85 
shown to be toxic to algae, although the MoA is poorly characterised (Backhaus et al., 2011, 86 
Escher et al., 2005).  87 
 88 
Even though the MoA of all biocides, PPCPs, PAHs and other organic contaminants are not 89 
fully known, it has been observed that compounds causing the same type of effect or having a 90 
similar MoA can be additive (Backhaus et al., 2011). The combined effects of chemicals can 91 
be studied by application of the two widely used prediction models for additive effects, the 92 
concentration addition (CA) and independent action (IA) prediction models. These concepts 93 
were first introduced by Loewe and Muischnek (1926, CA) and Bliss (1939, IA), and are 94 
based on the assumption that all the compounds in a mixture affect the same endpoint in the 95 
same direction, and that the compounds act by similar (CA) or dissimilar (IA) MoA. As the 96 
models work as a reference point for additive effects, deviations from the models indicate 97 
interactions such as synergy (more than additive effects) and antagonism (less than additive 98 
effects). Combined effects of pharmaceuticals or biocides have shown to be mostly additive in 99 
algae by following either CA or IA (Backhaus et al., 2011; Cleuvers, 2003; Cleuvers, 2004; 100 
Faust et al., 2003). Algae, including the diatoms Skeletonema costatum and Phaeodactylum 101 
tricornutum, are among the most sensitive groups of aquatic species used in regulatory testing 102 
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(Bjørnestad et al., 1993). Algal growth inhibition tests are routinely used in ecotoxicity testing 103 
of chemicals and environmental samples and international standards and guidelines are 104 
available for both freshwater and marine species (ISO, 2006; ISO, 2012; OECD, 2011). To 105 
accommodate high-throughput setups, microplate methods using smaller volumes have been 106 
developed and used for several algal species (Eisentraeger et al., 2003; Pavlic et al., 2006; 107 
Rojickova et al., 1998; Skjelbred et al., 2012; Vendrell et al., 2009).  108 
 109 
In this study we used an algal microplate method with Skeletonema pseudocostatum (formerly 110 
S. costatum), a spring bloom forming diatom found in coastal waters throughout non-polar 111 
regions (Kooistra et al., 2008), to investigate the combined effect of pollutants originating 112 
from a wide array of environmentally relevant compound groups; PPCPs, antifoulants, PAHs 113 
and alkylphenols. The investigated compounds were chosen based on demonstrated presence 114 
in the environment (Daughton and Ternes, 1999; Kümmerer, 2010; Schlabach et al., 2009; 115 
Thomas and Brooks, 2010), anticipated aquatic toxicity (Sanderson and Thomson 2009) 116 
and/or presence on the OSPAR list of chemicals for priority action (OSPAR, 2009). The 117 
microplate method has, with a few exceptions, been shown to produce EC50 values similar to 118 
the flask method after exposure for certain metals, pesticides, pharmaceuticals and 119 
environmental samples (Eisentraeger et al., 2003; Pavlic et al., 2006; Rojickova et al., 1998). 120 
The small volume, reduced use of laboratory resources and high throughput capacity of the 121 
microplate method makes this assay highly attractive for complex studies such as that 122 
addressing combined toxicity assessment. 123 
 124 
2. Materials and methods 125 
2.1. Test compounds 126 
The test compounds (table 1) 4-tert-octylphenol (OP, cas: 140-66-9), benzo(a)pyrene (BAP, 127 
cas: 50-32-8), benzophenone-3 (BP3, cas:131-57-7), cetrimonium bromide (cas: 57-09-0), 128 
diuron (cas: 330-54-1), endosulfan (cas: 115-29-7), fluoxetine HCl (cas: 56296-78-7), irgarol 129 
1051 (cas: 28159-98-0), propranolol (cas: 318-98-9), thioguanine (cas: 154-42-7) and 130 
triclosan (cas: 3380-34-5) were all from Sigma-Aldrich (St. Louis, MI, US). The chemicals, 131 
all with purity ≥96%, were dissolved in dimethylsulfoxide (DMSO) and stored at 4°C when 132 
not in use.  133 
 134 
 135 
 136 
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2.2. Skeletonema pseudocostatum microplate test 137 
Growth inhibition tests with S. pseudocostatum L.K. Medlin (formerly S. costatum Cleve) 138 
(NIVA-BAC1; Norwegian Institute for Water Research, Oslo, Norway) were performed in 139 
Nunc 96 well plates (Nunc A/S, Roskilde, Denmark). Algal cultures for inoculation were 140 
incubated in growth medium 1-4 days prior to the test to ensure that the cultures were in the 141 
exponential growth phase. The growth medium was made with 0.45µm filtered (HAWP 142 
membrane filter, Millipore Ireland Ltd, Tullagreen, Ireland) sea water collected at 60 m depth 143 
from the Outer Oslofjord supplemented with ISO10253 stock solutions (ISO, 2006). Algae 144 
concentrations were measured with a Beckman-Coulter Multisizer 3 Coulter Counter (Miami, 145 
FL, US) and adjusted to 1*104 cells mL-1. Test solutions were prepared by mixing 2 µl of 146 
stock solution or solvent (DMSO) with 998 µl growth medium and diluting 1:1 with algae 147 
culture (1*104 cells mL-1). The final volume in each well was 200 µl with a nominal algal 148 
concentration of 5*103 cells mL-1 and a solvent (DMSO) concentration of 0.1%. Nine 149 
concentrations plus solvent control were tested in 5 replicates per plate. One replicate without 150 
algal inoculum was used to detect fluorescence from the chemical alone. The outer wells of 151 
the microplates were filled with 200 µl growth medium without algae to counteract 152 
confounding bioassay factors such as edge-specific evaporation from the microplate. The 153 
plates were sealed with plate seals (Nunc, Roskilde, Denmark) and incubated in an Infors 154 
Multitron 2 incubator shaker (Infors AG, Bottmingen, Switzerland) with orbital shaking at 90 155 
rpm, continuous light intensity of 83 ± 6 µmol m-2s-1 and temperature of 20 ± 2°C. 156 
Fluorescence measurements with a 530 nm excitation filter, bandwidth 25 nm, and a 685 nm 157 
emission filter, bandwidth 20 nm, were performed at the start (only controls) and every 24 ± 2 158 
hours with a Cytofluor 2300 (Millipore, Billerica, MA, US). The fluorescence of test solution 159 
without algae was subtracted from each replicate. A concentration series of algae were 160 
measured with fluorescence, coulter counter and counted manually in a haemocytometer and 161 
showed good linear correlation (r2=0.99 and 0.98, respectively). At least three independent 162 
experiments were performed for each chemical and mixture. For cetrimonium bromide, a new 163 
dilution series with slightly different concentrations were prepared for each individual 164 
experiment. 165 
 166 
 167 
 168 
 169 
6 
 
The average growth rate for each sample was calculated from initial fluorescence and 170 
fluorescence after 72 hours using the equation (1): 171 
10 24
)ln()ln( 

 d
t
NN
n
n          (1) 172 
where N
n 
is the fluorescence at time t
n,
 N
0 
is the fluorescence at time zero (t
0
), tn is the time at  173 
nth measurement. Growth inhibition was calculated as percent of the control. 174 
 175 
2.3. Data analyses and mixture design 176 
Single compounds and mixtures were screened for growth inhibition in the S. pseudocostatum 177 
microplate test and the results were modeled with a non-linear regression using a sigmoidal 178 
dose-response curve (with variable slope) in the GraphPad prism software version 6 179 
(GraphPad Software Inc., La Jolla, CA, USA) (2). The bottom and top values were fixed at 0 180 
and 100 %, respectively.  181 
 182 
Y = Bottom + ((top-bottom)/(1+10^((logEC50-logX)*slope)))    (2) 183 
 184 
The parameters obtained from the individual concentration-response curves (CRCs, table 2) 185 
were used to design the mixtures. Binary mixtures consisting of biocides (irgarol + diuron), 186 
pharmaceuticals (thioguanine + fluoxetine), personal care products (triclosan + BP3) and 187 
classic organic contaminants (OP + BAP) were tested to assess whether compounds belonging 188 
to the same chemical group were acting additive. Binary (thioguanine + triclosan, fluoxetine + 189 
BP3) and an eight compound mixture (irgarol, diuron, triclosan, BP3, fluoxetine, thioguanine 190 
OP and BPA) of compounds from different chemical groups were tested to determine if the 191 
models were robust to more environmentally relevant complex mixtures. The compounds 192 
endosulfan, cetrimonium bromide and propranolol were excluded from the mixture design 193 
due to effect concentrations were above the water solubility (endosulfan), scattered data and 194 
bad curve fit (cetrimonium bromide) and a steep concentration-response curve with no tested 195 
concentrations causing effects between 0% and 100% growth inhibition (propranolol). A 196 
fixed ratio ray design was chosen, and equi-effective concentrations according to the CA 197 
model (3) were calculated based on the ratios of the EC50 values.  198 
 199 
 200 
 201 
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       n 202 
ECx(mix) = (∑(pi/ECxi))-1         (3) 203 
       i=1 204 
The ECx(mix) is the total predicted effect concentration of the mixture inducing an effect x, pi is 205 
the relative fraction of component i in the mixture and ECxi is the concentration of substance i 206 
needed to induce the effect x when applied alone. In addition, the prediction for IA (4) were 207 
calculated for the designed mixtures to define a window of expected additive effects as the 208 
MoA of all compounds in algae were not fully known.  209 
   n 210 
Emix = 1-∏(1-Ei)          (4) 211 
             i=1 212 
Emix is the effect of a mixture of n compounds and Ei is the effect of substance i when applied 213 
singly. 214 
The CRC for the experimental data was compared to CA and IA prediction and additive 215 
effects were believed to occur if the 95% confidence interval of the CRC for the observed 216 
data overlapped with either of the prediction models or if the calculated model deviation ratio 217 
(MDR) (5), were within a factor of 2 (0.5≤MDR≤2). The MDRs were calculated by dividing 218 
the observed effect concentrations (ECxobs) with the predicted effect concentrations (ECxpred). 219 
 220 
MDR = ECxobs/ECxpred         (5) 221 
 222 
3. Results 223 
The eleven tested compounds reduced the growth of Skeletonema pseudocostatum in a 224 
concentration-dependent manner to less than 50% of the control (table 2, figure 1). The 225 
observed responses for the eleven compounds were well explained by the applied non-linear 226 
regression with R2 values ≥ 0.86 for all compounds except cetrimonium bromide (R2=0.65) 227 
(table 2). Irgarol was the most toxic compound with an EC50 of 4.7 nM, and the order of 228 
toxicity was irgarol > fluoxetine > diuron > BAP > thioguanine > triclosan > propranolol > 229 
BP3 > cetrimonium bromide > OP > endosulfan. The EC50 values for the most toxic (irgarol) 230 
and the least toxic (endosulfan) compound differed by approximately three orders of 231 
magnitude (4.7 nM and 5.9 µM, respectively). Endosulfan induced effects at higher than the 232 
reported water-solubility of 0.8 µM (Kegley et al., 2011). The slope of the obtained 233 
concentration response-curves differed between the compounds with the steepest slope for 234 
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propranolol of -18 and the shallowest for thioguanine of -1.1. The three pesticides, irgarol, 235 
diuron and endosulfan exhibited similar slopes of -2.4, -2.3 and -2.3 respectively. 236 
 237 
[Insert Figure 1 here] 238 
[Insert table 2 here] 239 
 240 
Six binary mixtures (irgarol + diuron, triclosan + BP3, fluoxetine + BP3, thioguanine + 241 
fluoxetine, OP + BAP and thioguanine + triclosan) and an eight compound mixture (irgarol, 242 
diuron, triclosan, BP3, fluoxetine, thioguanine OP and BAP) were screened for growth 243 
inhibition in the S. pseudocostatum microplate test. The microplate test provided reproducible 244 
results that were well described by the applied non-linear regression analysis, indicated by R2 245 
≥ 0.93 for all mixtures. Most of the tested binary mixtures (figure 2) were well predicted by 246 
both models and MDR values were within a factor of 2 (table 3). The effect of two mixtures 247 
(OP + BAP and fluoxetine + BP3) was only predicted by CA, indicative of similar MoA of 248 
OP and BAP and of fluoxetine and BP3. The effect of the mixture of irgarol and diuron was 249 
better predicted by CA than by IA even though observed effect concentrations were within a 250 
factor of two from both prediction models. 251 
 252 
[Insert Figure 2 here] 253 
[Insert table 3 here] 254 
 255 
The effect of the eight-compound mixture was positioned in between the two prediction 256 
models and was well predicted by IA at the lower mixture concentrations but shifted towards 257 
CA predictions at the higher concentrations (figure 3). The positioning of the observed results 258 
in the window of additivity defined by the two prediction models indicated that the mixture 259 
consisted of compounds displaying a concentration-dependent MoA, e.g. exhibiting dissimilar 260 
MoA on low concentrations and similar MoA at high mixture concentrations.  261 
  262 
    [Insert Figure 3 here] 263 
 264 
 265 
 266 
 267 
 268 
 269 
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4. Discussion 270 
 271 
4.1. Effects of single compound exposure in the microplate test  272 
Of the 11 tested organic pollutants and PPCPs all but four (OP, BP3, cetrimonium bromide 273 
and endosulfan) had EC50 levels in the nM range (4.73-797nM). The two biocides irgarol and 274 
diuron were among the most potent inhibitors of the growth of S. pseudocostatum in our 275 
study. This was not surprising as these compounds are designed biocides, and inhibit growth 276 
specifically by inhibiting PSII (Jones, 2005). Interestingly, fluoxetine was the second most 277 
potent inhibitor of growth of S. pseudocostatum. Fluoxetine is a pharmaceutical used in 278 
antidepressiva and works by inhibiting serotonin reuptake into presynaptic cells and thereby 279 
increases the level of serotonin available for postsynaptic receptors in the synaptic cleft 280 
(Hiemke and Härtter, 2000). Fluoxetine is toxic to algae (Neuwoehner and Escher, 2011) and 281 
bacteria (Munoz-Bellido et al., 2000), and was observed to be more toxic to algae than to 282 
daphnids (Christensen et al., 2007). The mechanism by which fluoxetine is toxic to algae is 283 
not fully known, but it has been proposed that fluoxetine act through a narcotic MoA 284 
(Neuwoehner and Escher, 2011) and/or potentially by inhibiting cellular efflux pumps as 285 
observed in humans (Munoz-Bellido et al., 2000). Benzo(a)pyrene and thioguanine were the 286 
fourth and fifth most toxic of the tested compounds, respectively. A transriptomics study by 287 
Carvalho et al., (2011) revealed that BAP triggered a change in the lipid metabolism in 288 
diatoms, probably by incorporation and perturbation of cellular membranes. In addition, 289 
apoptosis was inhibited and the normal progression of the cell cycle was disrupted (indicative 290 
of an arrest of the cell cycle). The suggested arrest in the cell cycle progression was consistent 291 
with the decreased diatome growth rate (Carvalho et al., 2011) and could also be the MoA for 292 
growth inhibition in this study. Thioguanine is an anti-cancer drug which interferes with 293 
normal cellular function by incorporation into DNA as replacement for purine bases and 294 
subsequently causing increase in DNA strand breaks, triggering apoptotic and cytotoxic 295 
pathways (Krynetski et al., 2003; Kverka et al., 2011). The MoAs of the sixth most toxic 296 
compound, triclosan, in microalgae might be attributed to baseline toxicity and uncoupling of 297 
oxidative phosphorylation (Franz et al., 2008). Inhibition of non-photochemical quenching 298 
after exposure to triclosan has also been observed in river biofilms (Ricart et al., 2010). Non-299 
photochemical quenching is a mechanism that is used to dispose of excess energy when the 300 
light energy absorption exceeds the capacity for photosynthesis. Inhibition of non-301 
photochemical quenching might lead to damages in the pigments where the non-302 
photochemical quenching takes place (Ricart et al., 2010), ultimately reducing the 303 
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photosynthetic capacity of the cell. Propranolol with an EC50 for growth inhibition in S. 304 
pseudocostatum of 797 nM is a sympatholytic non-selective beta blocker used to treat anxiety, 305 
hypertensives, vasoconstriction and arrhythmia in human patients (Drugbank, 2013). 306 
Propranolol has been shown to be toxic to algae (Backhaus et al., 2011), and a narcotic MoA 307 
have been proposed (Neuwoehner and Escher, 2011). In addition, propranolol has been shown 308 
to reduce the photosynthetic capacity and efficiency of algae indicative of irreversible 309 
damages to the photosynthetic apparatus (Bonnineau et al., 2010). This damage could 310 
possibly be a result of oxidative stress, as an intermediate radical is formed during the 311 
photolysis of propranolol (Liu and Williams, 2007). Benzophenone was the fourth least toxic 312 
of the tested compounds with an EC50 of 1.1 µM. Rodil et al., (2009) found that the observed 313 
algal toxicity of BP3 was 42 times higher than that predicted based on baseline toxicity, and 314 
conclude that this is indicative of a more specific MoA of this substance to algae. In addition, 315 
the more polar properties of BP3 assume permeation through the algae membranes and might 316 
cause additional effects to the organism (Rodil et al., 2009). The third least toxic compound, 317 
cetrimonium bromide is accumulated in the mitochondrial matrix by a membrane potential 318 
driven uptake mechanism that may lead to toxicity by a collapse of the mitochondrial 319 
membrane potential (Bragadin and Dell’Antone, 1996). In addition, cetrimonium bromide 320 
may induce mitochondria-mediated apoptosis (Ito et al., 2009), which may reduce the growth 321 
of algae. 4-tert-octylphenol with an EC50 for growth inhibition of S. pseudocostatum of 5.6 322 
µM has previously been shown to inhibit the growth of algae, decrease the ratio of variable 323 
and maximal fluorescence, cause thickening and wrinkling of the cell wall matrix, and 324 
increase the number of starch granules with a reduced size (Zhou et al., 2013). An indication 325 
of an effect on the PSII primary photochemical events and inactivation of PSII reaction 326 
centres has also been observed (Perron and Juneau, 2011). The least toxic of the tested 327 
compounds, endosulfan, has been shown to inhibit PS II activity in cyanobacteria (Prasad et 328 
al., 2011).  329 
 330 
The observed results were comparable to previous reported EC50 levels as all but one (BAP) 331 
of the obtained EC50 values were within one order of magnitude from previously reported 332 
data, and the EC50 of four of the tested compounds (irgarol, diuron, fluoxetine, BP3) were 333 
within a factor of 2 from previous observed results (Cleuvers, 2005; DeLorenzo and Fleming, 334 
2008; Djomo et al., 2004; Gatidou and Thomaidis, 2007; Rodil et al., 2009; Sanderson and 335 
Thomsen, 2009). The EC50 of BAP was more than one order of magnitude higher in our study 336 
than previously reported for algae incubated for 7 days in glass flasks (Djomo et al., 2004), a 337 
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discrepancy that might be explained by the different species, test systems, and test duration 338 
used in these studies. As exposure concentrations were not verified by chemical analysis in 339 
the present study, differences between reported values and data obtained in our study could 340 
also be related to reduction in exposure concentration compared with the nominal 341 
concentration. Benzo(a)pyrene has a high logKow (5.97) and might adsorb to the plastic 342 
surface of the microplate well. Differences in adsorption of highly hydrophobic compounds 343 
due to different surface area to volume ratios between the microplate test and tests performed 344 
in glass vessels might also contribute to the observed discrepancy between EC50 for BAP in 345 
this study and previous reported data. A general loss of exposure concentration due to 346 
hydrophobicity and solubility limitations is expected for compounds with a logKow above 4 347 
(OECD, 2000), and chemicals with a logKoW > 3 have been observed to be less effective in 348 
the microplate assay than in traditional algal assays (Riedl and Altenburger, 2007). Although 349 
the microplate assay may potentially underestimate the effect of chemicals with logKow 350 
higher than 3, the individual compounds are expected to behave in a similar way when dosed 351 
in mixtures and thus accurately reflect the combined effects.  352 
 353 
4.2. Combined effects 354 
Acute toxicity to aquatic organisms by single human pharmaceuticals are unlikely to occur as 355 
environmental concentrations are 100-1000 times lower than acute effect concentrations and 356 
is only relevant in case of spills (Fent et al., 2006). However, PPCPs can add to the effect of 357 
other algae-toxic compounds like biocides, PAHs and alkylphenols as shown in this study. 358 
The present study clearly showed that complex mixtures of PPCPs (fluoxetine, thioguanine, 359 
triclosan and BP3), a PAH (BAP), an alkylphenol (OP) and biocides (irgarol and diuron) had 360 
additive effects on the growth inhibition of S. pseudocostatum. The results are in agreement 361 
with previous reported data on combined toxicity of mixtures of pharmaceuticals (Christensen 362 
et al., 2007; Cleuvers, 2003; Cleuvers, 2004), PPCPs (Backhaus et al., 2011; DeLorenzo and 363 
Fleming, 2008), biocides (Faust et al., 2003; Porsbring et al., 2010) and in a multi-compound 364 
mixture of priority pollutants (Walter et al., 2002). Although hormesis has been observed at 365 
the lower concentrations of a mixture of PPCPs, the higher concentration effects have been 366 
shown to follow the CA prediction (Backhaus et al., 2011).  367 
 368 
The binary mixture of irgarol and diuron was clearly additive and was best estimated by the 369 
CA model in our study. This was expected as they have the same mode of action, i.e. 370 
inhibition of PSII (Jones, 2005). Synergistic, antagonistic and additive effects have previously 371 
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been reported for mixtures of these two compounds on photosynthetic organisms (Chesworth 372 
et al., 2004; Koutsaftis and Aoyama, 2006). The effect on growth inhibition of the binary 373 
mixtures of fluoxetine and BP3, and of OP and BAP were additive according to the CA model 374 
and could not be predicted successfully by the IA model. These results are indicative of a 375 
similar MoA of the 2 compounds BP3 and fluoxetine and of the 2 environmental compounds 376 
OP and BAP. The MoA of fluoxetine and BP3 is not fully known but have been suggested to 377 
be through a specific MoA rather than just by baseline toxicity, possibly involving inhibition 378 
of cellular efflux pumps for fluoxetine (Munoz-Bellido et al., 2000). By assuming a similar 379 
MoA of these two compounds it can be hypothesised that BP3 have a specific, not yet 380 
identified, MoA on the algae which is in agreement with previous results obtained by Rodil et 381 
al. (2009) where a higher than baseline toxicity of BP3 was observed. The compounds OP and 382 
BAP can be expected to act by a narcotic MoA based on previously observed data (Carvalho 383 
et al., 2011; Zhou et al., 2013). However, other specific MoA have also been observed for 384 
these two compounds, including disruption of the cell cycle by BAP (Carvalho et al., 2011) 385 
and indications of inhibition of PSII by OP (Perron and Juneau, 2011). As the binary mixture 386 
of these two compounds (BAP and OP) followed the concept of CA, it can be hypothesized 387 
that the primary MoA of these two compounds is through a narcotic MoA, and that the other 388 
proposed specific MoA only contribute to a limited extent to the effects on the growth of S. 389 
pseudocostatum. The binary mixtures of triclosan and BP3, of thiogunaine and fluoxetine, and 390 
of thioguanine and triclosan were also found to be additive, but no distinction between the 391 
concept of CA or IA could be made as the MDRs where within a factor of 2 from both models 392 
for most of the effect range (table 3). 393 
 394 
The combined effect of the mixture of the eight selected compounds were additive as the 395 
observed effects were positioned between the two prediction models, sometimes referred to as 396 
the “window of additivity” (Altenburger et al., 2003; Faust et al., 2003). Interestingly, the 397 
observed effects were explained by the IA predictions at the lower concentrations and the CA 398 
predictions at the higher concentrations, indicating a shift from dissimilar MoAs at lower 399 
concentrations to a similar MoA at the higher concentrations. The 8-compound mixture 400 
includes compounds presumed to both act through an unspecific, specific and unknown MoA. 401 
Based on this information a position of the observed results between the two prediction 402 
models would be expected due to a combination of compounds with similar and dissimilar 403 
MoAs. However, the concentration-dependent shift from IA to CA with increasing 404 
concentrations has not been reported, nor properly characterized previously. At low 405 
13 
 
concentrations it is believed that the compound-specific MoAs are dominating the toxicity 406 
(van Wezel and Opperhuizen, 1995), whereas it can be speculated that an increase in the 407 
exposure concentration will gradually increase the contribution of unspecific MoA such as 408 
narcosis (baseline toxicity) and therefore cause a shift from IA to CA as baseline toxicity is 409 
known to be concentration additive (Mayer and Reichenberg, 2006). Alternatively, increasing 410 
the compound concentrations is expected to affect a higher number of biological targets and 411 
toxicity pathways that may affect each other (Hoffmann et al., 2006). Activation of 412 
converging toxicity pathways may thus lead to departure from independently acting MOAs 413 
and lead to a shift from IA to CA with increasing concentrations. As characterization of the 414 
MoA of the test compounds and mixtures of these in S. pseudocostatum was beyond the scope 415 
of this study, future studies to reveal the mechanistic rationale for a shift from IA to CA is 416 
clearly warranted.    417 
 418 
The marine algae S. pseudocostatum is found in coastal waters throughout the non-polar 419 
regions of the world (Kooistra et al., 2008). This makes it a relevant test species as most 420 
marine pollution originates from land-based sources, and coastal areas will most likely 421 
contain a mixture of PPCPs, biocides and classic organic pollutants like PAHs and 422 
alkylphenols. Growth inhibition of algae due to combined effects of contaminants may have 423 
implications on the aquatic ecosystem as algae are important for carbon fixation in oceans, 424 
providing food and oxygen to the aquatic ecosystem. In addition, algae are an important 425 
pathway for the accumulation of lipophilic water-borne contaminants and can serve as a 426 
source of contaminants to organisms at higher trophic levels (Dann and Hontela, 2011). 427 
Combined effects of organic pollutants might influence the structure and function of algal 428 
communities as have been observed after exposure to triclosan and two other PPCPs (Wilson 429 
et al., 2003). This might possibly lead to shifts in the nutrient processing capacity and food 430 
web structure, and effects on zooplankton associated with macrophytes through loss of habitat 431 
and food has been observed in a mesocosm study after exposure to irgarol (Mohr et al. 2008).  432 
 433 
Assessment of combined effects of chemicals from these and other compound groups by use 434 
of prediction models for additive effects (CA and IA) is becoming increasingly important in 435 
protecting the aquatic environment against undesired effects. Use of prediction models such 436 
as CA and IA to assess combined effects have proven successful in several studies, and in this 437 
study we showed that these models are also applicable for assessment of combined effects of 438 
14 
 
a diverse group of chemicals from different compound groups with both known and unknown 439 
MoA.  440 
 441 
5. Conclusion 442 
The combined effects of PPCPs, biocides, PAH and alkylphenol were tested on the growth 443 
inhibition of S. pseudocostatum in microplates. The combined effects of the binary mixtures 444 
used in this study were additive, and the effects were well estimated by CA and/or IA. The 8-445 
compound mixture of irgarol, diuron, thioguanine, fluoxetine, triclosan, BP3, BAP and OP, 446 
followed the IA predictions at the lower concentrations and the CA predictions at the higher 447 
total mixture concentrations, indicative of a shift from dissimilar to similar MoA. The shift 448 
from IA to CA is possibly linked to an increased number of activated targets and/or pathways 449 
leading to a higher possibility of the compounds to be involved in the same pathways, and/or 450 
a shift from a specific MoA at low concentrations to a general narcotic MoA at higher 451 
concentrations. This study show that PPCPs will contribute to the chemical load and increase 452 
the risk of adverse effects on marine organisms like S. pseudocostatum in coastal areas that 453 
are also contaminated with other organic pollutants like antifoulants, PAHs and alkylphenols.  454 
 455 
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Figure Legends 1 
 2 
Figure 1. Growth rate of Skeletonema pseudocostatum expressed as % of control after 3 
exposure to pharmaceuticals (fluoxetine, thioguanine, propranolol), biocides (irgarol, diuron), 4 
personal care products (benzophenone, cetrimonium bromide, triclosan), organic pollutants 5 
(benzo(a)pyrene, 4-tert-octylphenol, endosulfan). Results (●) are shown as mean values ± 6 
standard deviation of 3 independent studies. The concentration-response curves with 95% 7 
confidence interval were modelled by non-linear regression using a sigmoidal concentration-8 
response curve with variable slope.  The data for endosulfan was based on 1 study.  9 
 10 
Figure 2. Growth rate of Skeletonema pseudocostatum as % of control after exposure to 11 
different binary mixtures of pharmaceuticals, personal care products, biocides and organic 12 
contaminants. Results (●) are shown as mean values ± standard deviation of 4 independent 13 
studies. The concentration-response curves with 95% confidence interval were modelled by 14 
non-linear regression using a sigmoidal concentration-response curve with variable slope. The 15 
grey solid and broken lines are the concentration addition and independent action predictions, 16 
respectively. The data for the mixture of 4-tert-octylphenol + benzo(a)pyren were based upon 17 
3 independent studies. 18 
 19 
Figure 3. Growth rateof Skeletonema pseudocostatum as % of control after exposure to a 20 
mixture of 8 compounds; irgarol, diuron, triclosan, benzophenone, thioguanine, fluoxetine, 4-21 
tert-octylphenol and benzo(a)pyrene. Results (●) are shown as mean values ± standard 22 
deviation of 3 independent studies. The concentration-response curves with 95% confidence 23 
interval were modelled by non-linear regression using a sigmoidal concentration-response 24 
curve with variable slope. The grey solid and broken lines are the concentration addition and 25 
independent action predictions, respectively.  26 



Table 1. Chemical structure, use and mode of action of the test chemicals 
Compound Log KoW Structure Use/Origin Main Mode of action 
4-tert-
octylphenol 
cas: 140-66-9 
3.7a 
 
Various chemical industrial applications. 
Chemical intermediate mainly used to make 
phenolic resins for tire production (Brooke et 
al., 2005) 
Estrogen receptor agonist 
(Tollefsen et al., 2008) 
Benzo(a)pyrene 
cas: 50-32-8  
5.97a 
 
Byproduct of incomplete combustion or 
burning of organic materials (wood, gasoline, 
cigarettes etc) (EPA, 2007) 
Aryl-hydrocarbon receptor 
agonist, metabolite form 
DNA-adducts (EPA, 2007) 
Benzophenone 3 
cas: 131-57-7 
3.79c 
 
Used in sunscreens and cosmetics (SCCP, 
2008) 
Estrogenic, anti-estrogenic, 
anti-androgenic (Kunz and 
Fent, 2006) 
Cetrimonium 
bromide 
cas: 57-09-0 
3.18a 
 
Antiseptic agent (Thefreedictionary.com, 
2013)  
Ingredient in personal care products (Lush, 
2013)  
Mitochondria-mediated 
apoptosis (Ito et al., 2009) 
Diuron 
cas: 330-54-1 
2.64b 
 
Herbicide (Kegley et al., 2011). Used as an 
anti-fouling agent in boat paints (Voulvoulis 
et al., 2002)  
Inhibition of photosystem 
II (Jones, 2005) 
Endosulfan 
cas: 115-29-7 
3.83a 
 
Organochlorine insecticede used in 
agriculture (Kegley et al., 2011) 
Blocking of GABA-gated 
chlorine channels 
(Canadian Council of 
Ministers of the 
Environment, 2010) 
Fluoxetine 
cas: 56296-78-7 
1.8a 
4.09 
(Neuwoehner 
and Escher, 
2011) 
 
Antidepressant used against major depressive 
disorder, bulimia, obsessive-compulsive 
disorder, panic disorder etc. in humans 
(Daughton and Ternes, 1999; Drugs.com, 
2013)  
Selective serotonin 
reuptake inhibitor (Hiemke 
and Härtter, 2000) 
Irgarol 
cas: 28159-98-0 
3.9a 
 
Used as an anti-fouling agent in boat paints 
(Voulvoulis et al., 2002) 
Inhibition of photosystem 
II (Jones, 2005) 
Propranolol 
cas: 318-98-9 
-0.45 (pH2)c 
2.90 
(Neuwoehner 
and Escher, 
2011) 
 
Beta-blocker used against anxiety, 
hypertensives, vasoconstriction, arrhythmia 
(Drugbank, 2013) 
non-cardioselective beta-
adrenergic antagonist 
(Drugbank, 2013) 
Thioguanine 
cas: 154-42-7 
0.13b 
 
Cancer drug used in treatment of leukemia 
(Vora et al., 2006) 
Incorporates into DNA as 
replacement for purine 
bases (Kverka et al., 2011) 
Triclosan 
cas: 3380-34-5 
4.7a 
 
Antibacterial agent (Daughton and Ternes, 
1999) 
Targets the Fab1 
component of bacterial 
fatty acid synthesis (Heath 
et al., 1999) 
aValue from MSDS sheet, bobtained from ALOGPS, cobtained from http://pubchem.ncbi.nlm.nih.gov 
 
 
 
 
Table 2. Growth inhibition in Skeletonema pseudocostatum exposed to organic contaminants 
Compound EC50a growth inhibition (mol/L) Slopea Goodness of fit (R2)a 
4-tert-octylphenol 5.6E-6  (5.2E-6-6.1E-6)b -5.2 0.965 
Benzo(a)pyrene 6.8E-8  (6.2E-8-7.5E-8) -4.3 0.905 
Benzophenone 3 1.1E-6   (1.0E-6-1.2E-6) -3.2 0.974 
Cetrimonium bromide 4.5E-6   (2.5E-6–8.0E-6) -1.4 0.646 
Diuron 6.7E-8   (5.7E-8-7.8E-8) -2.3 0.929 
Endosulfanc 5.9E-6   (5.3E-6-6.6E-6) -2.3 0.985 
Fluoxetine 5.2E-8   (4.8E-8-5.5E-8) -4.6 0.962 
Irgarol 4.7E-9   (4.4E-9-5.2E-9) -2.4 0.981 
Propranolol 8.0E-7   (6.3E-7-1.0E-6) -18.0 0.998 
Thioguanine 8.5E-8   (6.7E-8-1.1E-7) -1.1 0.858 
Triclosan 9.5E-8   (8.3E-8-1.1E-7) -1.8 0.924 
aEC50, slope and R2 values are obtained from the fitted concentration-response curves. bValues 
in brackets show the 95% confidence intervals. cValues for endosulfan are based on one test 
only.  
Table 3. Model deviation ratios (MDRs) at different effect levels (% growth) for the seven tested mixtures 
 irgarol +  
diuron 
triclosan + 
benzophenone 
fluoxetine + 
benzophenone 
thioguanine + 
fluoxetine 
4-tert-octylphenol + 
benzo(a)pyrene 
thioguanine + 
triclosan 
8-compound 
mixture 
EC50=3.63E-8 mol/L EC50=6.37E-7 mol/L EC50=3.88E-7 mol/L  EC50=6.99E-8 mol/L EC50=2.05E-6 mol/L EC50=6.87E-8 mol/L EC50 =1.48E-6 mol/L 
% 
Growth 
MDRa 
CA 
MDR IA MDR 
CA 
MDR IA MDR 
CA 
MDR IA MDR 
CA 
MDR IA MDR 
CA 
MDR IA MDR 
CA 
MDR IA MDR 
CA 
MDR IA 
95 1.00 1.59 1.08 1.75 1.10 1.96 0.24 n.a 1.08 1.95 0.40 n.a. 0.21 0.71 
90 1.00 1.55 1.06 1.67 1.19 2.04 0.41 0.62 1.15 2.04 0.57 0.53 0.31 0.90 
80 0.99 1.50 1.01 1.52 1.28 2.14 0.60 0.95 1.23 2.12 0.78 0.96 0.40 1.12 
70 0.99 1.41 0.98 1.41 1.35 2.19 0.73 1.08 1.29 2.18 0.96 1.14 0.47 1.30 
60 0.99 1.37 0.95 1.33 1.41 2.24 0.85 1.17 1.33 2.22 1.13 1.28 0.53 1.45 
50 0.98 1.33 0.92 1.25 1.46 2.29 0.96 1.25 1.38 2.27 1.30 1.39 0.59 1.61 
40 0.98 1.28 0.90 1.18 1.52 2.33 1.08 1.33 1.43 2.31 1.50 1.50 0.66 1.78 
30 0.98 1.24 0.87 1.10 1.58 2.38 1.21 1.41 1.48 2.36 1.75 1.62 0.73 1.99 
20 0.98 1.19 0.83 1.01 1.66 2.45 1.35 1.50 1.55 2.42 2.08 1.77 0.82 2.27 
10 0.97 1.11 0.77 0.88 1.79 2.54 1.48 1.63 1.65 2.51 2.66 1.99 0.96 2.74 
5 0.97 1.04 0.70 0.77 1.90 2.62 1.48 1.71 1.75 2.59 3.20 2.17 1.06 3.19 
a the model deviation ratios (MDRs) were calculated by dividing the observed effect concentration by the effect concentration predicted by CA 
(MDR CA) or IA (MDR IA). Effect concentrations were calculated from the non-linear regression curve fits. Bold text indicates were MDRs are 
within a factor of two. 
